Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
Scope of the Report:
This report focuses on the Aprotinin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Currently, there are many sales companies in the world Aprotinin industry, especially in India and China. The main market players are Sigma-Aldrich, BeiJing Geyuantianrun Bio-tech, Cayman Chemical, Taj Pharmaceuticals Limited and Guangdong Techpool Bio-pharma. The sale Revenue of Aprotinin is about 123458 K USD in 2015.
North America is the largest consumption region of Aprotinin, with a Revenue market share nearly 20.28% in 2015.
The second consumption place is Europe; following North America with the Revenue market share of 19.66%. China is another important market of Aprotinin, enjoying 17.23% Revenue market share.
Aprotinin is used in Pharmaceuticals and Scientific Research & Experiment areas. Report data showed that 74.04% of the Aprotinin market demand in Pharmaceuticals and 25.96% in Scientific Research & Experiment areas in 2015.
There are three kinds of Aprotinin, which are Aprotinin (From bovine lung) and Recombinant Aprotinin. Aprotinin (From bovine lung) is wildly used in the Aprotinin, with a revenue market share nearly 81.11% in 2015.
Briefly speaking, in the next few years, Aprotinin industry will still be a highly energetic industry. Sales of Aprotinin have brought a lot of opportunities, there will more companies enter into this industry, especially in developing countries.
The worldwide market for Aprotinin is expected to grow at a CAGR of roughly 4.7% over the next five years, will reach 180 million US$ in 2023, from 140 million US$ in 2017, according to a new WMR study.
Market Segment by Manufacturers, this report covers
Sigma-Aldrich
BeiJing Geyuantianrun Bio-tech
Cayman Chemical
Taj Pharmaceuticals Limited
Guangdong Techpool Bio-pharma
Dadeli
A.S.Joshi&Company
Enzymeking Biotechnology
AdooQ BioScience
ProSpec
Yaxin Biotechnology
AMRESCO
PanReac AppliChem
Runhao
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Aprotinin (From bovine lung)
Recombinant Aprotinin
Market Segment by Applications, can be divided into
Pharmaceuticals
Scientific Research & Experiment
There are 15 Chapters to deeply display the global Aprotinin market.
Chapter 1, to describe Aprotinin Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Aprotinin, with sales, revenue, and price of Aprotinin, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Aprotinin, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Aprotinin market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Aprotinin sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source